SERUM APOLIPOPROTEINS IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA

被引:17
作者
KAJINAMI, K
MABUCHI, H
KOIZUMI, J
TAKEDA, R
机构
[1] The Second Department of Internal Medicine, School of Medicine, Kanazawa University, Kanazawa, 920
关键词
FAMILIAL HYPERCHOLESTEROLEMIA; APOLIPOPROTEIN;
D O I
10.1016/0009-8981(92)90108-3
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
In order to characterize the abnormalities of the lipoprotein pofile in familial hypercholesterolemia (FH), serum apolipoprotein Al, AII, B, CII, CIII, and E levels were determined by the turbidimetric immunoassay in 48 patients with heterozygous FH. Apolipoprotein B levels in FH were about 2.5 fold higher (203 +/- 48 mg/dl, mean +/- S.D.) than the 30 age-matched normolipidemic control subjects (84 +/- 13 mg/dl). Significant increments of apolipoprotein CII, CIII, and E levels were observed in FH (4.6 +/- 1.6, 11.0 +/- 3.6 and 6.4 +/- 1.7 mg/dl, respectively) as compared with those in normal subjects (3.0 +/- 0.9, 7.7 +/- 1.6 and 4.5 +/- 1.1 mg/dl, respectively). Apolipoprotein AI and AII levels in FH were 130 +/- 27 and 32 +/- 6.0 mg/dl, respectively, which were not significantly different from the levels in normal subjects (131 +/- 18 and 31 +/- 5.4 mg/dl, respectively). The ratio of low density lipoprotein (LDL) cholesterol to apolipoprotein B was significantly higher in FH (1.3 +/- 0.3) than that in normal subjects (1.2 +/- 0.1). This indicates that the LDL of FH was cholesterol-rich in comparison with that of normal subjects. The ratio of high density lipoprotein (HDL) cholesterol to apolipoprotein AI in FH (0.34 +/- 0.07) was significantly lower than that in normal subjects (0.39 +/- 0.05). This difference might possibly be produced by an abnormal HDL metabolism of FH patients, a topic which remains to be elucidated by further investigation.
引用
收藏
页码:93 / 99
页数:7
相关论文
共 15 条
[1]  
ALAUPOVIC P, 1988, CLIN CHEM, V34, pB13
[2]  
ALLAIN CC, 1974, CLIN CHEM, V20, P470
[3]  
BACKER GD, 1982, ATHEROSCLEROSIS, V42, P197
[4]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[5]   PLASMA-LIPOPROTEIN DISTRIBUTION OF APOLIPOPROTEIN-E IN FAMILIAL HYPERCHOLESTEROLEMIA [J].
GIBSON, JC ;
GOLDBERG, RB ;
RUBINSTEIN, A ;
GINSBERG, HN ;
BROWN, WV ;
BAKER, S ;
JOFFE, BI ;
SEFTEL, HC .
ARTERIOSCLEROSIS, 1987, 7 (04) :401-407
[6]   ABNORMALITIES OF HIGH-DENSITY LIPOPROTEINS IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA [J].
GOLDBERG, RB ;
FLESS, GM ;
BAKER, SG ;
JOFFE, BI ;
GETZ, GS ;
SCANU, AM ;
SEFTEL, HC .
ARTERIOSCLEROSIS, 1984, 4 (05) :472-478
[7]  
Goldstein J.L., 1989, METABOLIC BASIS INHE, P1215
[8]   ENHANCED CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITIES AND ABNORMALITIES OF HIGH-DENSITY-LIPOPROTEINS IN FAMILIAL HYPERCHOLESTEROLEMIA [J].
INAZU, A ;
KOIZUMI, J ;
MABUCHI, H ;
KAJINAMI, K ;
TAKEDA, R .
HORMONE AND METABOLIC RESEARCH, 1992, 24 (06) :284-288
[9]  
KAJIKAWA T, 1981, J JPN ATHEROSCLER SO, V9, P393
[10]   SERUM-LIPID AND LIPOPROTEIN LEVELS IN JAPANESE PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA [J].
MABUCHI, H ;
TATAMI, R ;
UEDA, K ;
UEDA, R ;
HABA, T ;
KAMETANI, T ;
WATANABE, A ;
WAKASUGI, T ;
ITO, S ;
KOIZUMI, J ;
OHTA, M ;
MIYAMOTO, S ;
TAKEDA, R .
ATHEROSCLEROSIS, 1979, 32 (04) :435-444